Sofinnova Partners SAS - Significant Ownership

Signature - Title
Sofinnova Partners SAS, a French corporation - Managing Partner
Location
Paris, France
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Partners SAS.

Significant Ownership of Sofinnova Partners SAS

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QNCX Quince Therapeutics, Inc. Common Stock, par value $0.001 per share 5.4% $3.38M 2.4M Sofinnova Capital VIII Dec 31, 2024

Schedules 13D/G Reported by Sofinnova Partners SAS:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.